Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Kazdal

Showing results (21-30 of 114) with videos related to

Pageof 12
Sort By:
Seminars in Cancer Biology|March 30, 2026
Bridging the gap between tumor evolution and clonality diagnostics in multiple lung carcinomasJurriaan Janssen, Michael Allgäuer, Bauke Ylstra, et al.
Seminars in Cancer Biology|May 11, 2026
Tumor microenvironment evaluation in lung cancer: Spatio-temporal dynamics and clinical implicationsSelma Dizdarević, Oleg Timofeev, Daniel Kazdal, et al.
British Journal of Cancer|April 18, 2025
Comprehensive genomic profiling requires a blended ecosystem of learning healthcare and clinical trialsAlbrecht Stenzinger, C Benedikt Westphalen, Jan Budczies, et al.
British Journal of Cancer|May 31, 2017
Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancerDaniel Kazdal, Alexander Harms, Volker Endris, et al.
Frontiers in Oncology|May 7, 2021
Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung CancerMei Elsayed, Farastuk Bozorgmehr, Daniel Kazdal, et al.
Diagnostic Pathology|September 13, 2018
Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancerMark Kriegsmann, Katharina Kriegsmann, Alexander Harms, et al.
International Journal of Cancer|October 24, 2018
Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomasSteffen Dietz, Aviezer Lifshitz, Daniel Kazdal, et al.
Lung Cancer (Amsterdam, Netherlands)|December 20, 2024
A novel clinical brain prognostic index for KRAS-mutated lung cancer and brain metastases (KRAS-BPI): Real-world evidence from two large European centersIoannis Zerdes, Caroline Kamali, Berglind Johannsdottir, et al.
British Journal of Clinical Pharmacology|October 10, 2023
Therapeutic drug monitoring of osimertinib in non-small cell lung cancer and short bowel syndrome: A case reportRémi Longuespée, Julia Kunz, Margaux Fresnais, et al.
Proteomics|December 14, 2017
Proteomics in PathologyRémi Longuespée, Rita Casadonte, Kristina Schwamborn, et al.
Pageof 12

Showing results (21-30 of 114) with videos related to

Sort By:
Pageof 12
Seminars in Cancer Biology|March 30, 2026
Bridging the gap between tumor evolution and clonality diagnostics in multiple lung carcinomasJurriaan Janssen, Michael Allgäuer, Bauke Ylstra, et al.
Seminars in Cancer Biology|May 11, 2026
Tumor microenvironment evaluation in lung cancer: Spatio-temporal dynamics and clinical implicationsSelma Dizdarević, Oleg Timofeev, Daniel Kazdal, et al.
British Journal of Cancer|April 18, 2025
Comprehensive genomic profiling requires a blended ecosystem of learning healthcare and clinical trialsAlbrecht Stenzinger, C Benedikt Westphalen, Jan Budczies, et al.
British Journal of Cancer|May 31, 2017
Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancerDaniel Kazdal, Alexander Harms, Volker Endris, et al.
Frontiers in Oncology|May 7, 2021
Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung CancerMei Elsayed, Farastuk Bozorgmehr, Daniel Kazdal, et al.
Diagnostic Pathology|September 13, 2018
Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancerMark Kriegsmann, Katharina Kriegsmann, Alexander Harms, et al.
International Journal of Cancer|October 24, 2018
Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomasSteffen Dietz, Aviezer Lifshitz, Daniel Kazdal, et al.
Lung Cancer (Amsterdam, Netherlands)|December 20, 2024
A novel clinical brain prognostic index for KRAS-mutated lung cancer and brain metastases (KRAS-BPI): Real-world evidence from two large European centersIoannis Zerdes, Caroline Kamali, Berglind Johannsdottir, et al.
British Journal of Clinical Pharmacology|October 10, 2023
Therapeutic drug monitoring of osimertinib in non-small cell lung cancer and short bowel syndrome: A case reportRémi Longuespée, Julia Kunz, Margaux Fresnais, et al.
Proteomics|December 14, 2017
Proteomics in PathologyRémi Longuespée, Rita Casadonte, Kristina Schwamborn, et al.
Pageof 12